 | • レポートコード：GIR-107A14835 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ニコチンアミドホスホリボシルトランスフェラーゼのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ニコチンアミドホスホリボシルトランスフェラーゼの種類別市場規模（ホルモン、脂質、小分子化合物、その他）、用途別市場規模（パーキンソン病、急性肺損傷、乳がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ニコチンアミドホスホリボシルトランスフェラーゼの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Genentech, Inc.、Angelini Group、Calico LLC、FORMA Therapeutics, Inc.、OncoTartis, Inc.、Karyopharm Therapeutics, Inc.、Aurigene Discovery Technologies Limited ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ホルモン、脂質、小分子化合物、その他 ・用途別分析2016年-2026年：パーキンソン病、急性肺損傷、乳がん、その他 ・ニコチンアミドホスホリボシルトランスフェラーゼの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ニコチンアミドホスホリボシルトランスフェラーゼのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ニコチンアミドホスホリボシルトランスフェラーゼのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ニコチンアミドホスホリボシルトランスフェラーゼの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ニコチンアミドホスホリボシルトランスフェラーゼの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Nicotinamide Phosphoribosyltransferase market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Nicotinamide Phosphoribosyltransferase size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Nicotinamide Phosphoribosyltransferase market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Nicotinamide Phosphoribosyltransferase market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Hormone
Lipids
Small Molecule Compounds
Others
Market segment by Application can be divided into
Parkinson’s Disease
Acute Lung Injury
Breast Cancer
Others
The key market players for global Nicotinamide Phosphoribosyltransferase market are listed below:
Genentech, Inc.
Angelini Group
Calico LLC
FORMA Therapeutics, Inc.
OncoTartis, Inc.
Karyopharm Therapeutics, Inc.
Aurigene Discovery Technologies Limited
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Nicotinamide Phosphoribosyltransferase product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nicotinamide Phosphoribosyltransferase, with price, sales, revenue and global market share of Nicotinamide Phosphoribosyltransferase from 2019 to 2021.
Chapter 3, the Nicotinamide Phosphoribosyltransferase competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nicotinamide Phosphoribosyltransferase breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Nicotinamide Phosphoribosyltransferase market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Nicotinamide Phosphoribosyltransferase sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Nicotinamide Phosphoribosyltransferase Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nicotinamide Phosphoribosyltransferase Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Hormone
1.2.3 Lipids
1.2.4 Small Molecule Compounds
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Nicotinamide Phosphoribosyltransferase Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Parkinson’s Disease
1.3.3 Acute Lung Injury
1.3.4 Breast Cancer
1.3.5 Others
1.4 Global Nicotinamide Phosphoribosyltransferase Market Size & Forecast
1.4.1 Global Nicotinamide Phosphoribosyltransferase Sales in Value (2016-2026))
1.4.2 Global Nicotinamide Phosphoribosyltransferase Sales in Volume (2016-2026)
1.4.3 Global Nicotinamide Phosphoribosyltransferase Price by Type (2016-2026) & (USD/MT)
1.5 Global Nicotinamide Phosphoribosyltransferase Production Capacity Analysis
1.5.1 Global Nicotinamide Phosphoribosyltransferase Total Production Capacity (2016-2026)
1.5.2 Global Nicotinamide Phosphoribosyltransferase Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nicotinamide Phosphoribosyltransferase Market Drivers
1.6.2 Nicotinamide Phosphoribosyltransferase Market Restraints
1.6.3 Nicotinamide Phosphoribosyltransferase Trends Analysis
2 Manufacturers Profiles
2.1 Genentech, Inc.
2.1.1 Genentech, Inc. Details
2.1.2 Genentech, Inc. Major Business
2.1.3 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Product and Services
2.1.4 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Angelini Group
2.2.1 Angelini Group Details
2.2.2 Angelini Group Major Business
2.2.3 Angelini Group Nicotinamide Phosphoribosyltransferase Product and Services
2.2.4 Angelini Group Nicotinamide Phosphoribosyltransferase Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Calico LLC
2.3.1 Calico LLC Details
2.3.2 Calico LLC Major Business
2.3.3 Calico LLC Nicotinamide Phosphoribosyltransferase Product and Services
2.3.4 Calico LLC Nicotinamide Phosphoribosyltransferase Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 FORMA Therapeutics, Inc.
2.4.1 FORMA Therapeutics, Inc. Details
2.4.2 FORMA Therapeutics, Inc. Major Business
2.4.3 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product and Services
2.4.4 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 OncoTartis, Inc.
2.5.1 OncoTartis, Inc. Details
2.5.2 OncoTartis, Inc. Major Business
2.5.3 OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Product and Services
2.5.4 OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Karyopharm Therapeutics, Inc.
2.6.1 Karyopharm Therapeutics, Inc. Details
2.6.2 Karyopharm Therapeutics, Inc. Major Business
2.6.3 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product and Services
2.6.4 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Aurigene Discovery Technologies Limited
2.7.1 Aurigene Discovery Technologies Limited Details
2.7.2 Aurigene Discovery Technologies Limited Major Business
2.7.3 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Product and Services
2.7.4 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Nicotinamide Phosphoribosyltransferase Sales by Manufacturer
3.1 Global Nicotinamide Phosphoribosyltransferase Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Nicotinamide Phosphoribosyltransferase
3.4 Market Concentration Rate
3.4.1 Top 3 Nicotinamide Phosphoribosyltransferase Manufacturer Market Share
3.4.2 Top 6 Nicotinamide Phosphoribosyltransferase Manufacturer Market Share
3.5 Global Nicotinamide Phosphoribosyltransferase Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Nicotinamide Phosphoribosyltransferase Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Nicotinamide Phosphoribosyltransferase Market Size by Region
4.1.1 Global Nicotinamide Phosphoribosyltransferase Sales in Volume by Region (2016-2026)
4.1.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Region (2016-2026)
4.2 North America Nicotinamide Phosphoribosyltransferase Revenue (2016-2026)
4.3 Europe Nicotinamide Phosphoribosyltransferase Revenue (2016-2026)
4.4 Asia-Pacific Nicotinamide Phosphoribosyltransferase Revenue (2016-2026)
4.5 South America Nicotinamide Phosphoribosyltransferase Revenue (2016-2026)
4.6 Middle East and Africa Nicotinamide Phosphoribosyltransferase Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Nicotinamide Phosphoribosyltransferase Sales in Volume by Type (2016-2026)
5.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Type (2016-2026)
5.3 Global Nicotinamide Phosphoribosyltransferase Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Nicotinamide Phosphoribosyltransferase Sales in Volume by Application (2016-2026)
6.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Application (2016-2026)
6.3 Global Nicotinamide Phosphoribosyltransferase Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Nicotinamide Phosphoribosyltransferase Sales by Type (2016-2026)
7.2 North America Nicotinamide Phosphoribosyltransferase Sales by Application (2016-2026)
7.3 North America Nicotinamide Phosphoribosyltransferase Market Size by Country
7.3.1 North America Nicotinamide Phosphoribosyltransferase Sales in Volume by Country (2016-2026)
7.3.2 North America Nicotinamide Phosphoribosyltransferase Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Nicotinamide Phosphoribosyltransferase Sales by Type (2016-2026)
8.2 Europe Nicotinamide Phosphoribosyltransferase Sales by Application (2016-2026)
8.3 Europe Nicotinamide Phosphoribosyltransferase Market Size by Country
8.3.1 Europe Nicotinamide Phosphoribosyltransferase Sales in Volume by Country (2016-2026)
8.3.2 Europe Nicotinamide Phosphoribosyltransferase Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales by Type (2016-2026)
9.2 Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales by Application (2016-2026)
9.3 Asia-Pacific Nicotinamide Phosphoribosyltransferase Market Size by Region
9.3.1 Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Nicotinamide Phosphoribosyltransferase Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Nicotinamide Phosphoribosyltransferase Sales by Type (2016-2026)
10.2 South America Nicotinamide Phosphoribosyltransferase Sales by Application (2016-2026)
10.3 South America Nicotinamide Phosphoribosyltransferase Market Size by Country
10.3.1 South America Nicotinamide Phosphoribosyltransferase Sales in Volume by Country (2016-2026)
10.3.2 South America Nicotinamide Phosphoribosyltransferase Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales by Type (2016-2026)
11.2 Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales by Application (2016-2026)
11.3 Middle East & Africa Nicotinamide Phosphoribosyltransferase Market Size by Country
11.3.1 Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Nicotinamide Phosphoribosyltransferase Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Nicotinamide Phosphoribosyltransferase Typical Distributors
12.3 Nicotinamide Phosphoribosyltransferase Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Nicotinamide Phosphoribosyltransferase Revenue by Type, (USD Million), 2021-2026
Table 2. Global Nicotinamide Phosphoribosyltransferase Revenue by Application, (USD Million), 2021-2026
Table 3. Genentech, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Genentech, Inc. Major Business
Table 5. Genentech, Inc. Nicotinamide Phosphoribosyltransferase Product and Services
Table 6. Genentech, Inc. Nicotinamide Phosphoribosyltransferase Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Angelini Group Basic Information, Manufacturing Base and Competitors
Table 8. Angelini Group Major Business
Table 9. Angelini Group Nicotinamide Phosphoribosyltransferase Product and Services
Table 10. Angelini Group Nicotinamide Phosphoribosyltransferase Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Calico LLC Basic Information, Manufacturing Base and Competitors
Table 12. Calico LLC Major Business
Table 13. Calico LLC Nicotinamide Phosphoribosyltransferase Product and Services
Table 14. Calico LLC Nicotinamide Phosphoribosyltransferase Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. FORMA Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 16. FORMA Therapeutics, Inc. Major Business
Table 17. FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product and Services
Table 18. FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. OncoTartis, Inc. Basic Information, Manufacturing Base and Competitors
Table 20. OncoTartis, Inc. Major Business
Table 21. OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Product and Services
Table 22. OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Karyopharm Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Karyopharm Therapeutics, Inc. Major Business
Table 25. Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product and Services
Table 26. Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Aurigene Discovery Technologies Limited Basic Information, Manufacturing Base and Competitors
Table 28. Aurigene Discovery Technologies Limited Major Business
Table 29. Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Product and Services
Table 30. Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Nicotinamide Phosphoribosyltransferase Sales by Manufacturer (2019-2021e) & (K MT)
Table 32. Global Nicotinamide Phosphoribosyltransferase Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Nicotinamide Phosphoribosyltransferase, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Nicotinamide Phosphoribosyltransferase Production Capacity by Company, (K MT): 2020 VS 2021
Table 35. Head Office and Nicotinamide Phosphoribosyltransferase Production Site of Key Manufacturer
Table 36. Nicotinamide Phosphoribosyltransferase New Entrant and Capacity Expansion Plans
Table 37. Nicotinamide Phosphoribosyltransferase Mergers & Acquisitions in the Past Five Years
Table 38. Global Nicotinamide Phosphoribosyltransferase Sales by Region (2016-2021e) & (K MT)
Table 39. Global Nicotinamide Phosphoribosyltransferase Sales by Region (2021-2026) & (K MT)
Table 40. Global Nicotinamide Phosphoribosyltransferase Revenue by Region (2016-2021e) & (USD Million)
Table 41. Global Nicotinamide Phosphoribosyltransferase Revenue by Region (2021-2026) & (USD Million)
Table 42. Global Nicotinamide Phosphoribosyltransferase Sales by Type (2016-2021e) & (K MT)
Table 43. Global Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (K MT)
Table 44. Global Nicotinamide Phosphoribosyltransferase Revenue by Type (2016-2021e) & (USD Million)
Table 45. Global Nicotinamide Phosphoribosyltransferase Revenue by Type (2021-2026) & (USD Million)
Table 46. Global Nicotinamide Phosphoribosyltransferase Price by Type (2016-2021e) & (USD/MT)
Table 47. Global Nicotinamide Phosphoribosyltransferase Price by Type (2021-2026) & (USD/MT)
Table 48. Global Nicotinamide Phosphoribosyltransferase Sales by Application (2016-2021e) & (K MT)
Table 49. Global Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (K MT)
Table 50. Global Nicotinamide Phosphoribosyltransferase Revenue by Application (2016-2021e) & (USD Million)
Table 51. Global Nicotinamide Phosphoribosyltransferase Revenue by Application (2021-2026) & (USD Million)
Table 52. Global Nicotinamide Phosphoribosyltransferase Price by Application (2016-2021e) & (USD/MT)
Table 53. Global Nicotinamide Phosphoribosyltransferase Price by Application (2021-2026) & (USD/MT)
Table 54. North America Nicotinamide Phosphoribosyltransferase Sales by Country (2016-2021e) & (K MT)
Table 55. North America Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2026) & (K MT)
Table 56. North America Nicotinamide Phosphoribosyltransferase Revenue by Country (2016-2021e) & (USD Million)
Table 57. North America Nicotinamide Phosphoribosyltransferase Revenue by Country (2021-2026) & (USD Million)
Table 58. North America Nicotinamide Phosphoribosyltransferase Sales by Type (2016-2021e) & (K MT)
Table 59. North America Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (K MT)
Table 60. North America Nicotinamide Phosphoribosyltransferase Sales by Application (2016-2021e) & (K MT)
Table 61. North America Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (K MT)
Table 62. Europe Nicotinamide Phosphoribosyltransferase Sales by Country (2016-2021e) & (K MT)
Table 63. Europe Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2026) & (K MT)
Table 64. Europe Nicotinamide Phosphoribosyltransferase Revenue by Country (2016-2021e) & (USD Million)
Table 65. Europe Nicotinamide Phosphoribosyltransferase Revenue by Country (2021-2026) & (USD Million)
Table 66. Europe Nicotinamide Phosphoribosyltransferase Sales by Type (2016-2021e) & (K MT)
Table 67. Europe Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (K MT)
Table 68. Europe Nicotinamide Phosphoribosyltransferase Sales by Application (2016-2021e) & (K MT)
Table 69. Europe Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (K MT)
Table 70. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales by Region (2016-2021e) & (K MT)
Table 71. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales by Region (2021-2026) & (K MT)
Table 72. Asia-Pacific Nicotinamide Phosphoribosyltransferase Revenue by Region (2016-2021e) & (USD Million)
Table 73. Asia-Pacific Nicotinamide Phosphoribosyltransferase Revenue by Region (2021-2026) & (USD Million)
Table 74. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales by Type (2016-2021e) & (K MT)
Table 75. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (K MT)
Table 76. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales by Application (2016-2021e) & (K MT)
Table 77. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (K MT)
Table 78. South America Nicotinamide Phosphoribosyltransferase Sales by Country (2016-2021e) & (K MT)
Table 79. South America Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2026) & (K MT)
Table 80. South America Nicotinamide Phosphoribosyltransferase Revenue by Country (2016-2021e) & (USD Million)
Table 81. South America Nicotinamide Phosphoribosyltransferase Revenue by Country (2021-2026) & (USD Million)
Table 82. South America Nicotinamide Phosphoribosyltransferase Sales by Type (2016-2021e) & (K MT)
Table 83. South America Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (K MT)
Table 84. South America Nicotinamide Phosphoribosyltransferase Sales by Application (2016-2021e) & (K MT)
Table 85. South America Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (K MT)
Table 86. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales by Country (2016-2021e) & (K MT)
Table 87. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2026) & (K MT)
Table 88. Middle East & Africa Nicotinamide Phosphoribosyltransferase Revenue by Country (2016-2021e) & (USD Million)
Table 89. Middle East & Africa Nicotinamide Phosphoribosyltransferase Revenue by Country (2021-2026) & (USD Million)
Table 90. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales by Type (2016-2021e) & (K MT)
Table 91. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (K MT)
Table 92. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales by Application (2016-2021e) & (K MT)
Table 93. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (K MT)
Table 94. Direct Channel Pros & Cons
Table 95. Indirect Channel Pros & Cons
Table 96. Nicotinamide Phosphoribosyltransferase Typical Distributors
Table 97. Nicotinamide Phosphoribosyltransferase Typical Customers
List of Figures
Figure 1. Nicotinamide Phosphoribosyltransferase Picture
Figure 2. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Type in 2020
Figure 3. Hormone
Figure 4. Lipids
Figure 5. Small Molecule Compounds
Figure 6. Others
Figure 7. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Application in 2020
Figure 8. Parkinson's Disease
Figure 9. Acute Lung Injury
Figure 10. Breast Cancer
Figure 11. Others
Figure 12. Global Nicotinamide Phosphoribosyltransferase Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 13. Global Nicotinamide Phosphoribosyltransferase Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Nicotinamide Phosphoribosyltransferase Sales (2016-2026) & (K MT)
Figure 15. Global Nicotinamide Phosphoribosyltransferase Price by Type (2016-2026) & (USD/MT)
Figure 16. Global Nicotinamide Phosphoribosyltransferase Production Capacity (2016-2026) & (K MT)
Figure 17. Global Nicotinamide Phosphoribosyltransferase Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Nicotinamide Phosphoribosyltransferase Market Drivers
Figure 19. Nicotinamide Phosphoribosyltransferase Market Restraints
Figure 20. Nicotinamide Phosphoribosyltransferase Market Trends
Figure 21. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Manufacturer in 2020
Figure 22. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Manufacturer in 2020
Figure 23. Nicotinamide Phosphoribosyltransferase Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Nicotinamide Phosphoribosyltransferase Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Nicotinamide Phosphoribosyltransferase Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Region (2016-2026)
Figure 27. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Region (2016-2026)
Figure 28. North America Nicotinamide Phosphoribosyltransferase Revenue (2016-2026) & (USD Million)
Figure 29. Europe Nicotinamide Phosphoribosyltransferase Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Nicotinamide Phosphoribosyltransferase Revenue (2016-2026) & (USD Million)
Figure 31. South America Nicotinamide Phosphoribosyltransferase Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Nicotinamide Phosphoribosyltransferase Revenue (2016-2026) & (USD Million)
Figure 33. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2016-2026)
Figure 34. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Type (2016-2026)
Figure 35. Global Nicotinamide Phosphoribosyltransferase Price by Type (2016-2026) & (USD/MT)
Figure 36. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2016-2026)
Figure 37. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Application (2016-2026)
Figure 38. Global Nicotinamide Phosphoribosyltransferase Price by Application (2016-2026) & (USD/MT)
Figure 39. North America Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2016-2026)
Figure 40. North America Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2016-2026)
Figure 41. North America Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2016-2026)
Figure 42. North America Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country (2016-2026)
Figure 43. United States Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2016-2026)
Figure 47. Europe Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2016-2026)
Figure 48. Europe Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2016-2026)
Figure 49. Europe Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country (2016-2026)
Figure 50. Germany Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Nicotinamide Phosphoribosyltransferase Revenue Market Share by Region (2016-2026)
Figure 59. China Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2016-2026)
Figure 66. South America Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2016-2026)
Figure 67. South America Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2016-2026)
Figure 68. South America Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
化粧品用ニコチンアミドの世界市場 2019年版：種類別（2.5％未満、2.5％〜5％、5％以上）、用途別（化粧品、スキンケア製品） Scope of the Report: The worldwide market for Cosmetics Grade Nicotinamide is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Cosmetics …- 世界のホルモン不応性乳がん市場 2021：企業別、地域別、種類・用途別 The Hormone Refractory Breast Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界の腫瘍用小分子薬剤市場 2021：企業別、地域別、種類・用途別 The Oncology Small Molecule Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界のがんホルモン療法剤市場 2021：企業別、地域別、種類・用途別 The Cancer Hormone Therapy Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の腫瘍学小分子薬市場予測（～2024年）：企業別、地域別、種類・用途別 Scope of the Report: The global Oncology Small Molecule Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in Ch…